SPY396.48-11.84 -2.90%
DIA319.24-7.86 -2.40%
IXIC11,584.40-400.12 -3.34%

Myovant Sciences' Prostate Cancer Drug Receives European Commission Approval

MT Newswires · 05/02/2022 02:31

Please log in to view news